1. Quotes

    1-10 of 796 1 2 3 4 ... 78 79 80 »
    1. Publisher: businesswire.com
      This is a tremendously exciting approach to granting that fosters the innovative thinking and scientific collaboration that are critical for the future of breast cancer research.
      - In “How Does Breast Cancer Develop?” Pilot Grants Awarded to Multidisciplinary Teams Using the Intraductal Approach to Advance Breast Cancer Prevention
    2. Publisher: uk.finance.yahoo.com
      OSA is greatly honored to recognize these leaders in the field of optics.
      - In The Optical Society Bestows Fifteen Prestigious Awards for 2015
    3. Publisher: Optical Coherence Tomography News
      We believe there will be huge demand for MRO™ sensors in fast-growing markets such as fingerprint device authentication and mobile health monitoring. This collaboration with IPIC comes at a critical time for Compact Imaging as we move our optical sensor technology from the engineering lab to manufacturing. We’re grateful for the support we’re receiving from IPIC, an institution at the forefront of photonics integration technology.
      - Don Bogue in Compact Imaging Selected to Partner with Leading Irish Research Center to Further Develop Disruptive Technology
    4. Publisher: Optical Coherence Tomography News
      we are very proud of the fact that our systems development work allows ELAN Vascular to take their application to trial on diseased animals with the goals of the development project meet 100%.
      - Douglas Hamilton in Real-time OCT guidance of an ablation laser for advancement in the fight of atherosclerotic cardio-vascular disease
    5. Publisher: Duke Today
      Ultimately, our goal is to try to understand how this pathway influences cardiac hypertrophy, not only within the context of specific conditions like Noonan syndrome, but also in the more general context of hypertension and high blood pressure, with the hopes of finding new targets to treat this disease.
      - In Scientists Identify Genetic Cues for a Big Heart
    6. Publisher: Optical Coherence Tomography News
      Jon Holmes, Co-Founder, Michelson Diagnostics, added: “delighted that Andy has joined the team at Michelson as CEO. Our ability to attract a CEO with such impressive credentials is a testament both to the team’s achievements to date and to the potential commercial opportunity of the VivoSight OCT system in non-melanoma skin cancer. With Andy now on board to spearhead our commercial growth, I look forward to driving the VivoSight OCT technology development and clinical validation into other clinical applications where we believe it can make a significant impact on patient diagnosis and treatment monitoring.
      - Jon Holmes in Andy Hill Appointed Chief Executive Officer of Michelson Diagnostics
    7. Publisher: Optical Coherence Tomography News
      Our miniature OCT architecture, MRO™, can be implemented within the size, cost and power requirements of mobile and wearable devices...These new patents further expand our IP coverage of the space, providing partners and licensees robust protection for the investments they make in bringing products that incorporate MRO™ sensors to market.
      - Don Bogue in Compact Imaging Granted Three New Patents for Miniature OCT Technology
    8. Publisher: Crain's Cleveland Business
      Innovation in health care is an ongoing journey for all of us. The current state of change in the health care environment provides many opportunities to be more pioneering with our roles in providing the highest-quality care and most personalized experiences for our patients.
      - Marco A. Costa in University Hospitals names Marco A. Costa as vice president and chief
    9. Publisher: Crain's Cleveland Business
      Marco epitomizes the ideal of a global physician-scientist who is, at heart, an innovator. He combines a scientific mindset with creativity to achieve extraordinary results.
      - In University Hospitals names Marco A. Costa as vice president and chief
    10. Publisher: businesswire.com
      We are excited to add these two highly accomplished industry and academic leaders to round out our Board. Their strategic support and guidance will be key as we continue to advance our ophthalmology pipeline toward commercialization including our lead product candidate, EBI-005.
      - In Eleven Biotherapeutics Appoints Barry Gertz, MD, PhD, and Jay S. Duker, MD, to Board of Directors
    1-10 of 796 1 2 3 4 ... 78 79 80 »
  1. Categories

    1. Applications:

      Art, Cardiology, Dentistry, Dermatology, Developmental Biology, Gastroenterology, Gynecology, Microscopy, NDE/NDT, Neurology, Oncology, Ophthalmology, Other Non-Medical, Otolaryngology, Pulmonology, Urology
    2. Business News:

      Acquisition, Clinical Trials, Funding, Other Business News, Partnership, Patents
    3. Technology:

      Broadband Sources, Probes, Tunable Sources
    4. Miscellaneous:

      Jobs & Studentships, Student Theses, Textbooks
  2. Most Quoted Topics